A. Millier

Quality of life is predictive of relapse in schizophrenia

Laurent Boyer, A. Millier, E. Perthame et al. · BMC Psychiatry · 2013 · 104 citations · Full text

Cost-effectiveness analysis of pembrolizumab versus standard-of-care chemotherapy for first-line treatment of PD-L1 positive (>50%) metastatic squamous and non-squamous non-small cell lung cancer in France

C. Chouaïd, L. Bensimon, E. Clay et al. · Lung Cancer · 2018 · 69 citations · Full text

Equipercentile linking of scales measuring functioning and symptoms: Examining the GAF, SOFAS, CGI-S, and PANSS

Myrto Samara, Rolf R. Engel, A. Millier et al. · European Neuropsychopharmacology · 2014 · 66 citations

Neuropsychology, Psychiatry, Equipercentile Linking +7

Attitudes and beliefs of the French public about schizophrenia and major depression: results from a vignette-based population survey

Matthias C. Angermeyer, A. Millier, C. Rémuzat et al. · BMC Psychiatry · 2013 · 59 citations · Full text

Drug reformulations and repositioning in the pharmaceutical industry and their impact on market access: regulatory implications

Susana Murteira, A. Millier, Zied Ghezaiel et al. · Journal of Market Access & Health Policy · 2014 · 48 citations · Full text